Off-label prescription advertising, the FDA and the first amendment: A study in the values of commercial speech protection

Coleen Klasmeier*, Martin H. Redish

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Off-label prescription advertising, the FDA and the first amendment: A study in the values of commercial speech protection'. Together they form a unique fingerprint.